2 blue chip ASX 200 shares that could be strong buys

Ramsay Health Care Limited (ASX:RHC) and this blue chip ASX 200 share could be strong buys now. Here's why they are highly rated by analysts…

| More on:
A man with a yellow background makes an annoncement, indicating share price changes on the ASX

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're aiming to build a balanced portfolio, having a few blue chip ASX shares in there could be a smart move.

But which blue chip ASX 200 shares should you buy? Two that are highly rated are listed below:

CSL Limited (ASX: CSL)

The first blue chip ASX 200 share to look at is biotechnology giant CSL.

CSL has a focus on rare and serious diseases through its CSL Behring business and influenza vaccines through its Seqirus business.

CSL Behring has a wide range of innovative therapies. These are used to treat immunodeficiencies, bleeding disorders, hereditary angioedema, Alpha 1 antitrypsin deficiency, and neurological disorders. Whereas Seqirus has a broad range of flu products meeting the needs of different populations around the world.

While COVID-19 has impacted its plasma collections and could weigh on its margins in the near term, the long term looks extremely positive. Especially given its burgeoning R&D pipeline and the increasing demand for plasma-based products.

This morning, analysts at Credit Suisse upgraded CSL's shares to an outperform rating with a $315.00 price target.

Ramsay Health Care Limited (ASX: RHC)

Another ASX 200 blue chip share to look at is Ramsay Health Care. It is a leading private healthcare company with operations across the world.

While the pandemic hit Ramsay hard and led to a significant drop in elective surgeries, trading conditions have improved greatly in recent months. As a result, Ramsay looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

Macquarie is positive on the company. Earlier this week its analysts retained their outperform rating and $75.00 price target on Ramsay's shares.

The broker has been pleased with recent activity trends and feels the company is well-positioned for growth over the long term.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Blue Chip Shares

Smiling couple sitting on a couch with laptops fist pump each other.
Blue Chip Shares

2 dirt cheap ASX 200 blue chip shares to buy now with $10,000

Analysts think these cheap shares could be top buys.

Read more »

Young female investor smiling and speaking on mobile phone while sitting in front of laptop
Blue Chip Shares

Down 28% and 23%! Should I buy either of these 2 iconic ASX 200 shares?

These ASX blue-chips are trading at much cheaper prices. Are they buys to me?

Read more »

Multiracial happy young people stacking hands outside - University students hugging in college campus - Youth community concept with guys and girls standing together supporting each other.
Blue Chip Shares

5 ASX 200 blue chip shares to buy in FY26 with $5,000

Analysts think these shares could be top picks for the new financial year.

Read more »

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Blue Chip Shares

2 ASX stocks to hold for steady gains

Analysts think these stocks could deliver the goods for investors.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Blue Chip Shares

The best ASX 200 blue chip shares to buy now with $3,000

Let's see why analysts think these are among the best stocks to buy right now.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Blue Chip Shares

Are these ASX 200 blue-chip shares undervalued?

Could now be time to jump in on these struggling blue chip holdings?

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Blue Chip Shares

The best blue chip ASX 200 shares to buy this month

Let's see which blue chips are best buys according to analysts at Bell Potter.

Read more »

Blue chips with stock written on them.
Blue Chip Shares

Why these ASX blue-chip shares are top buys for this fund manager

Here are two of the most appealing ASX blue-chip shares.

Read more »